A longitudinal assessment of the effect of inhaled fluticasone propionate therapy on adrenal function and growth in young children with asthma (Pediatirc Pulmonology (2008) 43, 4 (354-359) DOI: 10.1002/ppul.20770);A longitudinal assessment of the effect of inhaled fluticasone propionate therapy on adrenal function and growth in young children with asthma

Pediatric Pulmonology

Volumn 43, Issue 4, 2008, Pages 354-359

  Iles, R ^a,c   Williams, R W ^b   Deeb, A ^b   Ross Russell, R ^a   Acerini, C L ^b  

^a CAMBRIDGE UNIVERSITY HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^c ADDENBROOKE S HOSPITAL   (United Kingdom)

Author keywords

Adrenal function; BMI; Bronchial asthma; Fluticasone propionate; Growth

Indexed keywords

FLUTICASONE PROPIONATE; SALBUTAMOL; TETRACOSACTIDE;

ADRENAL FUNCTION; ARTICLE; ASTHMA; BODY MASS; CHILD GROWTH; CLINICAL ARTICLE; CORTICOSTEROID THERAPY; CORTICOTROPIN TEST; FEMALE; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; INFANT; LONGITUDINAL STUDY; MALE; PRESCHOOL CHILD; PRIORITY JOURNAL; SIDE EFFECT; WEIGHT GAIN;

EID: 42149101560     PISSN: 87556863     EISSN: 10990496     Source Type: Journal    
DOI: 10.1002/ppul.20872     Document Type: Erratum

References (40)

1. Harding SM. The human pharmacology of fluticasone propionate. Respir Med 1990;84:25-29.
2. Sharek PJ, Bergman DA. The effect of inhaled steroids on the linear growth of children with asthma: a meta-analysis. Pediatrics 2000;106:62-68.
3. Allen DB, Bronsky EA, LaForce CF, Nathan RA, Tinkelman DG, Vandewalker ML, Konig P. Growth in asthmatic children treated with fluticasone propionate. Fluticasone Propionate Asthma Study Group. J Paediatr 1998;132:472-477.
4. Price JF, Russell G, Hindmarsh P, Weller PH, Heaf DP, Williams J. Growth during one year of treatment with fluticasone propionate or sodium cromoglycate in children with asthma. Pediatr Pulmonol 1997;24:178-186.
5. Todd GR, Acerini CL, Ross-Russell R, Zahra S, Warner JT, McCane D. Survey of adrenal crisis associated with inhaled corticosteroids in the United Kingdom. Arch Dis Child 2002;87:457-461.
6. Wong JY, Zacharin MR, Hocking N, Robinsom PJ. Growth and adrenal suppression in asthmatic children on moderate to high doses of fluticasone propionate. J Paediatr Child Health 2002;38:59-62.
7. Eid N, Morton R, Olds B, Clark P, Sheikh S, Looney S. Decreased morning serum cortisol levels in children with asthma with inhaled fluticasone propionate. Pediatrics 2002;110:1030-1031.
8. Taylor AV, Laoprasert N, Zimmerman D, Sachs MI. Adrenal suppression secondary to inhaled fluticasone propionate. Ann Allergy Asthma Immunol 1999;83:68-70.
9. Kannisto S, Korppi M, Remes K, Voutilainen R. Adrenal suppression, evaluated by a low dose adrenocorticotropin test, and growth in athmatic children treated with inhaled steroids. J Clin Endo Metab 2000;85:652-657.
10. Russell G. Inhaled corticosteroid therapy in children: an assessment of the potential for side effects. Thorax 1994;49:1185-1188.
11. Bisgaard H, Gillies J, Groenewald M, Maden C. The effect of inhaled fluticasone propionate in the treatment of young asthmatic children. Am J Respir Criti Care Med 1999;160:126.
12. Clark PM, Neylon I, Raggatt PR, Sheppard MC, Stewart PM. Defining the normal cortisol response to the short Synacthen test: implications for the investigation of hypothalamic-pituitary disorders. Clin Endocrinol 1998;49:287-292.
13. Freeman JV, Cole TJ, Chinn S, Jones PR, White EM, Preece MA. Cross sectional stature and weight reference curves for the UK, 1990. Arch Dis Child 1995;73:17-24.
14. Bisgaard H, Allen D, Milanowski J, Kalev I, Willits L, Davies P. Twelve-month safety and efficacy of inhaled fluticasone propionate in children aged 1 to 3 years with recurrent wheezing. Pediatrics 2004;113:87-94.
15. Teper AM, Colom AJ, Kofman CD, Maffey AF, Vidaurreta SM, Bergadá I. Effects of inhaled fluticasone propionate in children less than 2 years old with recurrent wheezing. Pediatr Pulmonol 2004;37:111-115.
16. Patel L, Wales JK, Kibirigie MS, Massarano AA, Couriel JM, Clayton PE. Symptomatic adrenal insufficiency during inhaled corticosteroid treatment. Arch Dis Child 2001;85:330-334.
17. Yiallouros PK, Milner AD, Conway E, Honour JW. Adrenal function and high dose inhaled corticosteroids for asthma. Arch Dis Child 1997;76:405-410.
18. Weintrob N, Sprecher E, Josefsberg Z, Weininger C, Aurbach-Klipper Y, Lazard D, Karp M, Pertzelan A. Standard and low-dose short adrenocorticotropin test compared with insulin-induced hypoglycemia for assessment of the hypothalamic-pituitary-adrenal axis in children with idiopathic multiple pituitary hormone deficiencies. J Clin Endo Metab 1998;83:88-92.
19. Stewart PM, Corrie J, Seckl JR, Edwards CR, Padfield PL. A rational approach for assessing the hypothalamo-pituitary-adrenal axis. Lancet 1988;28:1208-1210.
20. Abdu TAM, Elhadd TA, Neary R, Clayton RN. Comparison of the low dose short Synacthen test (1 μg), the conventional dose short Synacthen test (250 μg), and the Insulin tolerance test for assessment of the hypothalamo-pituitary-adrenal axis in patients with pituitary disease. J Clin Endo metab 1999;84:838-843.
21. Mayenknecht J, Diederich S, Bähr V, Plöckinger U, Oelkers W. Comparison of low and high dose corticotropin stimulation tests in patients with pituitary disease. J Clin Endo Metab 1998;83:1558-1562.
22. Sim D, Griffiths A, Armstrong D, Clarke C, Rodda C, Freezer N. Adrenal suppression from high-dose inhaled fluticasone propionated in children with asthma. Eur Respir J 2003;21:633-636.
23. Todd G, Kunlop K, McNaboe J, Ryan MF, Carson D, Shields MD. Growth and adrenal suppression in asthmatic children treated with high-dose fluticasone propionate. Lancet 1996;348:27-29.
24. Drake AJ, Howells RJ, Shield JP, Prendiville A, Ward PS, Crowne EC. Symptomatic adrenal insufficiency presenting with hypoglycaemia in children with asthma receiving high dose inhaled fluticasone propionate. BMJ 2002;324:1081-1082.
25. Mahachoklertwattana P, Sudkronrayudh K, Direkwattanachai C, Choubtum L, Okascharoen C. Decreased cortisol response to insulin induced hypoglycaemia in asthmatics treated with inhaled fluticasone propionate. Arch Dis Child 2004;89:1055-1058.
26. Huizenga NATM, Koper JW, De Lange P, Pols HAP, Stolk RP, Burger H, Grobbee DE, Brinkmann AO, De Jong FH, Lamberts SW. A polymorphism in the glucocorticoid receptor gene may be associated with an increased sensitivity to glucocorticoids in vivo. J Clin Endo Metab 1998;83:144-151.
27. Ruiz M, Lind U, Gaevel M, Eggertsen JG, Carlstedt-Duke J, Nilsson L, Stierna P, Wikstrom A, Werner S. Characterization of two novel mutations in the glucocorticoid receptor gene in patients with primary cortisol resistance. Clin Endocrinol 2001;55:363-371.
28. Stevens A, Ray DW, Zeggini E, John S, Richard HL, Griffiths CE, Donn R. Glucocorticoid sensitivity is determined by a specific glucocorticoid receptor haplotype. J Clin Endo Metab 2004;89:892-897.
29. Allen DB, Julius JR, Breen TJ, Attie KM. Treatment of glucocorticoid-induced adrenal suppression with growth hormone. National cooperative growth study. J Clin Endo metab 1998;83:2824-2829.
30. Allen S. British guideline on the management of asthma. Thorax 2003;58:i1-94.
31. Tinkelman DG, Reed CE, Nelson HS, Offord KP. Aerosol beclomethasone dipropionate compared with theophylline as primary treatment of chronic, mild to moderately severe asthma in children. Pediatrics 1993;92:144-146.
32. Doull IJ, Freezer NJ, Holgate ST. Growth of prepubertal children with mild asthma treated with inhaled beclomethasone dipropionate. Am J Respir Crit Care Med 1995;151:1715-1719.
33. Simons FE. A comparison of beclomethasone, salmeterol, and placebo in children with asthma. Canadian Beclomethasone Dipropionate-Salmeterol Xinafoate Study Group. N Engl J Med 1997;337:1659-1665.
34. Agertoft L, Pedersen S. Effect of long-term treatment with inhaled budesonide on adult height in children with asthma. N Engl J Med 2000;343:1064-1069.
35. Lau EM, Li M, Woo J, Lai C. Bone mineral density and body composition in patients with airflow obstruction - The role of inhaled steroid therapy, disease and lifestyle. Clin Exp Allergy 1998;28:1066-1071.
36. Salvatoni A, Nosetti L, Broggini M, Nespoli L. Body composition and growth in asthmatic children treated with inhaled steroids. Ann Allergy Asthma Immunol 2000;85:221-226.
37. Agertoft L, Pedersen S. Bone mineral density in children with asthma receiving long-term treatment with inhaled budesonide. Am J Respir Crit Care Med 1998;157:178-183.
38. Rolland-Cachera MF, Deheeger M, Bellisle F. Adiposity rebound in children: a simple indicator for predicting obesity. Am J Clin Nutr 1984;39:129-135.
39. Stettler B, Zemel BS, Kumanyika S, Stallings VA. Infant weight gain and childhood overweight status in a multicenter, cohort study. Pediatrics 2002;109:194-199.
40. Weiss R, Dziura J, Burgert TS, Tamborlane WV, Taksali SE, Yeckel CW, Allen K, Lopes M, Savoye M, Morrison J, Sherwin RS, Caprio S. Obesity and the metabolic syndrome in children and adolescents. N Engl J Med 2004;350:2362-2374.